Your browser doesn't support javascript.
loading
V3: an enigmatic isoform of the proteoglycan versican.
Wight, Thomas N; Day, Anthony J; Kang, Inkyung; Harten, Ingrid A; Kaber, Gernot; Briggs, David C; Braun, Kathleen R; Lemire, Joan M; Kinsella, Michael G; Hinek, Aleksander; Merrilees, Mervyn J.
Affiliation
  • Wight TN; Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States.
  • Day AJ; Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
  • Kang I; Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
  • Harten IA; Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom.
  • Kaber G; Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States.
  • Briggs DC; Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States.
  • Braun KR; Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States.
  • Lemire JM; Signalling and Structural Biology Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Kinsella MG; Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States.
  • Hinek A; Department of Biology, Tufts University, Medford, Massachusetts, United States.
  • Merrilees MJ; Matrix Biology Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States.
Am J Physiol Cell Physiol ; 325(2): C519-C537, 2023 08 01.
Article in En | MEDLINE | ID: mdl-37399500
ABSTRACT
V3 is an isoform of the extracellular matrix (ECM) proteoglycan (PG) versican generated through alternative splicing of the versican gene such that the two major exons coding for sequences in the protein core that support chondroitin sulfate (CS) glycosaminoglycan (GAG) chain attachment are excluded. Thus, versican V3 isoform carries no GAGs. A survey of PubMed reveals only 50 publications specifically on V3 versican, so it is a very understudied member of the versican family, partly because to date there are no antibodies that can distinguish V3 from the CS-carrying isoforms of versican, that is, to facilitate functional and mechanistic studies. However, a number of in vitro and in vivo studies have identified the expression of the V3 transcript during different phases of development and in disease, and selective overexpression of V3 has shown dramatic phenotypic effects in "gain and loss of function" studies in experimental models. Thus, we thought it would be useful and instructive to discuss the discovery, characterization, and the putative biological importance of the enigmatic V3 isoform of versican.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alternative Splicing / Versicans Limits: Humans Language: En Journal: Am J Physiol Cell Physiol Journal subject: FISIOLOGIA Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alternative Splicing / Versicans Limits: Humans Language: En Journal: Am J Physiol Cell Physiol Journal subject: FISIOLOGIA Year: 2023 Type: Article Affiliation country: United States